EpiPen® 300mcg adrenaline autoinjector supply issue

Australian Clinical Society of Allergy and Immunology has just informed Allergists that Mylan (who distrubitue Epipens) has announced a shortage of EpiPen® 300mcg adrenaline (epinephrine) autoinjectors. Supply of EpiPen® Jr 150mcg adrenaline (epinephrine) autoinjectors is unaffected. Stock is expected to be available in pharmacies from mid-February 2018.  A process has been put in place by Mylan[…]

Some additional information re:EpiPen Junior shortage from ASCIA

  Supply of EpiPen® Jr with 30 November 2017 expiry during temporary shortage Mylan Australia (which supplies EpiPens in Australia) is experiencing a temporary shortage of EpiPen® Jr 150mcg adrenaline (epinephrine) autoinjectors. This supply disruption is due to an unforeseen delay in supply from the overseas manufacturer. Mylan expects stock to be available mid-to-late November[…]

Accidental self injection of EpiPens

We recently reported a case of a 9 year old non-allergic boy who accidentally injected his sister’s EpiPen into his thumb (see http://onlinelibrary.wiley.com/doi/10.1111/jpc.13553/full). Of interest we found in 2015 the Australian Database of Adverse Event Notifications documented no cases of self-injection (or ‘Injury associated with device’) for EpiPen or EpiPen Jr but in the same period, there were[…]

EpiPens only need to be left in place now for 3 seconds (not 10 seconds)

Normally it is instructed that EpiPen® and EpiPen® Jr adrenaline (epinephrine) autoinjectors are held in place for 10 seconds and that after removal the site of injection is rubbed. This advice has now changed. The devices have not changed, just the instruction on the label, which will now include: Reduced injection time from 10 to 3 seconds[…]

Influenza vaccination and egg allergy

Winter is fast approaching and the influenza vaccine is one way to reduce the risk of infection from certain strains of the influenza virus. The influenza (or flu) virus can be especially serious for elderly people, pregnant women, Aboriginal and Torres Strait Islander people and in young children, as well as for people with underlying medical conditions.[…]